Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 44, 2406-2409, June 1, 1984]
© 1984 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoon, D. B. S.
Right arrow Articles by Ramshaw, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoon, D. B. S.
Right arrow Articles by Ramshaw, I.

Circulating Immune Complexes in Rats Bearing 6-Thioguanine-resistant Variants of the 13762 Mammary Adenocarcinoma1

Dave B. S. Hoon2, Barry Ziola3 and Ian Ramshaw

Department of Microbiology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N 0W0 [D. B. S. H., B. Z.], and Department of Experimental Pathology, John Curtin School of Medical Research, Canberra A.C.T., Australia [I. R.]

The relationship between immune complex (IC) formation and tumor cell metastatic potential was investigated in rats inoculated in the footpad with parental 13762 mammary adenocarcinoma cells or 6-thioguanine-resistant (TGR) variant cells. These cell lines are either highly metastatic (13762), nonmetastatic (TGR), or occasionally metastatic (TGRrev, TGRrevM). The 13762 TGR rat tumor model thus provides the opportunity to examine host immune responses to tumor cells of different phenotypes, but derived from the same parent tumor line. IC levels were low in 13762 tumor-bearing rats. In contrast, animals with TGR tumors had high levels of ICs in their sera, while animals bearing TGRrev and TGRrevM tumors had intermediate levels of ICs. In this rat tumor model system, IC formation is inversely related to the metastatic potential of the tumor lines.

1 This research was supported by an Operating Grant from the National Cancer Institute of Canada.

2 Recipicient of a Saskatchewan Health Research Board Student Fellowship. Present address: Department of Surgery, Division of Oncology, 54–140 CHS, UCLA School of Medicine, Los Angeles, CA 90024.

3 Recipient of a Development Grant from the Medical Council of Canada. To whom requests for reprints should be addressed.

Received 8/29/83. Accepted 3/ 6/84.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
B. Taback, K. Hashimoto, C. T. Kuo, A. Chan, A. E. Giuliano, and D. S. B. Hoon
Molecular Lymphatic Mapping of the Sentinel Lymph Node
Am. J. Pathol., October 1, 2002; 161(4): 1153 - 1161.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1984 by the American Association for Cancer Research.